{"entity":{"type":"insider","cik":"0001618273","url":"/insider/0001618273","json_url":"/insider/0001618273.json","name":"Kalowski Lee","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":18,"first":"2015-04-06","last":"2026-02-27","span_basis":"filed_date"},"name_variants":[{"name":"Kalowski Lee","source":"filing","n_filings":18,"first_seen":"2015-04-06","last_seen":"2026-02-27"}],"transactions":[{"id":6087624,"accession":"0001193125-26-083588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-083588","line_url":"/filing/0001193125-26-083588#line-1","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (CFO and President)","role_mark":"O","role_mark_label":"Officer (CFO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3995.0,"shares_display":"3,995","price_per_share":4.5144,"price_display":"4.51","price_state":"stated","total_value":18035.028,"total_display":"18,035.03","total_whole":"18,035","shares_owned_after":35943.0,"shares_owned_after_display":"35,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-27","scope":"insider"},{"id":4298690,"accession":"0001193125-25-308327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-308327","line_url":"/filing/0001193125-25-308327#line-1","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (CFO and President)","role_mark":"O","role_mark_label":"Officer (CFO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9072.0,"shares_display":"9,072","price_per_share":3.4607,"price_display":"3.46","price_state":"stated","total_value":31395.4704,"total_display":"31,395.47","total_whole":"31,395","shares_owned_after":39938.0,"shares_owned_after_display":"39,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":4845093,"accession":"0001193125-25-191442","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-191442","line_url":"/filing/0001193125-25-191442#line-1","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (CFO and President)","role_mark":"O","role_mark_label":"Officer (CFO and President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4240.0,"shares_display":"4,240","price_per_share":1.801,"price_display":"1.80","price_state":"stated","total_value":7636.24,"total_display":"7,636.24","total_whole":"7,636","shares_owned_after":49010.0,"shares_owned_after_display":"49,010","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":8289844,"accession":"0001209191-23-023347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-023347","line_url":"/filing/0001209191-23-023347#line-1","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":376.0,"shares_display":"376","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":7937.36,"total_display":"7,937.36","total_whole":"7,937","shares_owned_after":30309.0,"shares_owned_after_display":"30,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8435254,"accession":"0001209191-23-002190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002190","line_url":"/filing/0001209191-23-002190#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1815.0,"shares_display":"1,815","price_per_share":29.06,"price_display":"29.06","price_state":"stated","total_value":52743.9,"total_display":"52,743.90","total_whole":"52,744","shares_owned_after":30685.0,"shares_owned_after_display":"30,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":4342474,"accession":"0001209191-21-054792","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-054792","line_url":"/filing/0001209191-21-054792#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-03","scope":"insider"},{"id":5001282,"accession":"0001209191-21-053710","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-053710","line_url":"/filing/0001209191-21-053710#line-4","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7950.0,"shares_display":"7,950","price_per_share":35.15,"price_display":"35.15","price_state":"stated","total_value":279442.5,"total_display":"279,442.50","total_whole":"279,443","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-27","scope":"insider"},{"id":5001268,"accession":"0001209191-21-053710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053710","line_url":"/filing/0001209191-21-053710#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":550.0,"shares_display":"550","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":19272.0,"total_display":"19,272.00","total_whole":"19,272","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-27","scope":"insider"},{"id":5252645,"accession":"0001209191-21-053350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053350","line_url":"/filing/0001209191-21-053350#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":33.02,"price_display":"33.02","price_state":"stated","total_value":247650.0,"total_display":"247,650.00","total_whole":"247,650","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-25","scope":"insider"},{"id":4954205,"accession":"0001209191-21-048919","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-048919","line_url":"/filing/0001209191-21-048919","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":31.5058048,"price_display":"31.51","price_state":"stated","total_value":393822.56,"total_display":"393,822.56","total_whole":"393,823","shares_owned_after":3504.0,"shares_owned_after_display":"3,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-30","scope":"insider","n_lines":3},{"id":4361810,"accession":"0001209191-21-004665","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-004665","line_url":"/filing/0001209191-21-004665#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","total_whole":"450,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":4715493,"accession":"0001209191-21-003826","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-003826","line_url":"/filing/0001209191-21-003826#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-15","scope":"insider"},{"id":2913661,"accession":"0001209191-20-061720","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-061720","line_url":"/filing/0001209191-20-061720#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":168750.0,"total_display":"168,750.00","total_whole":"168,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider"},{"id":2383194,"accession":"0001209191-20-060741","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-060741","line_url":"/filing/0001209191-20-060741#line-2","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":530.0,"shares_display":"530","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10600.0,"total_display":"10,600.00","total_whole":"10,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-27","filed_date":"2020-11-30","scope":"insider"},{"id":2252778,"accession":"0001209191-20-060598","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-060598","line_url":"/filing/0001209191-20-060598#line-5","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9781.0,"shares_display":"9,781","price_per_share":20.07,"price_display":"20.07","price_state":"stated","total_value":196304.67,"total_display":"196,304.67","total_whole":"196,305","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-25","scope":"insider"},{"id":2252768,"accession":"0001209191-20-060598","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-060598","line_url":"/filing/0001209191-20-060598","is_derivative":false,"issuer_cik":"0001618273","issuer_name":"BICYCLE THERAPEUTICS plc","issuer_ticker":"BCYC","issuer_name_source":null,"issuer_url":"/issuer/0001618273","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (President and CFO)","role_mark":"O","role_mark_label":"Officer (President and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CFO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17189.0,"shares_display":"17,189","price_per_share":19.8269393216592,"price_display":"19.83","price_state":"stated","total_value":340805.26,"total_display":"340,805.26","total_whole":"340,805","shares_owned_after":213.0,"shares_owned_after_display":"213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider","n_lines":2},{"id":8112538,"accession":"0001562180-15-000731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000731","line_url":"/filing/0001562180-15-000731#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4668.0,"shares_display":"4,668","price_per_share":13.13,"price_display":"13.13","price_state":"stated","total_value":61290.84,"total_display":"61,290.84","total_whole":"61,291","shares_owned_after":40953.0,"shares_owned_after_display":"40,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-08","filed_date":"2015-09-08","scope":"insider"},{"id":8222730,"accession":"0001562180-15-000728","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000728","line_url":"/filing/0001562180-15-000728#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2158.0,"shares_display":"2,158","price_per_share":12.96,"price_display":"12.96","price_state":"stated","total_value":27967.68,"total_display":"27,967.68","total_whole":"27,968","shares_owned_after":45621.0,"shares_owned_after_display":"45,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-02","filed_date":"2015-09-04","scope":"insider"},{"id":8941401,"accession":"0001562180-15-000300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-15-000300","line_url":"/filing/0001562180-15-000300#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4567.0,"shares_display":"4,567","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":59371.0,"total_display":"59,371.00","total_whole":"59,371","shares_owned_after":47779.0,"shares_owned_after_display":"47,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-16","filed_date":"2015-04-20","scope":"insider"},{"id":8598708,"accession":"0001209191-15-032711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-032711","line_url":"/filing/0001209191-15-032711#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Tokai Pharmaceuticals Inc","issuer_ticker":"TKAI","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001618273","owner_name":"Kalowski Lee","owner_display_name":"Kalowski Lee","owner_url":"/insider/0001618273","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2258.0,"shares_display":"2,258","price_per_share":11.45,"price_display":"11.45","price_state":"stated","total_value":25854.1,"total_display":"25,854.10","total_whole":"25,854","shares_owned_after":52346.0,"shares_owned_after_display":"52,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-02","filed_date":"2015-04-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Q32 Bio Inc.","url":"/issuer/0001661998","role":"Officer (CFO and President)","n_filings":3,"first_seen":"2025-08-28","last_seen":"2026-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001761612","name":"BICYCLE THERAPEUTICS plc","url":"/issuer/0001761612","role":"Officer (President and CFO)","n_filings":11,"first_seen":"2020-11-25","last_seen":"2023-04-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Tokai Pharmaceuticals Inc","url":"/issuer/0001404281","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2015-04-06","last_seen":"2015-09-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618273","retrieved_at":"2026-08-25T11:47:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}